Department of Orthopedics, The Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China (mainland).
Department of Orthopedics, Taizhou University Affiliated Municipal Hospital, Taizhou, Zhejiang, China (mainland).
Med Sci Monit. 2024 May 25;30:e944157. doi: 10.12659/MSM.944157.
BACKGROUND Micro-needle knife (MNK) therapy releases the superficial fascia to alleviate pain and improve joint function in patients with acute ankle sprains (AAS). We aimed to evaluate the efficacy and safety of MNK therapy vs that of acupuncture. MATERIAL AND METHODS This blinded assessor, randomized controlled trial allocated 80 patients with AAS to 2 parallel groups in a 1: 1 ratio. The experimental group received MNK therapy; the control group underwent conventional acupuncture treatment at specified acupoints. Clinical efficacy differences between the 2 groups before (time-point 1 [TP1]) and after treatment (TP2) were evaluated using the visual analogue scale (VAS) and Kofoed ankle score. Safety records and evaluations of adverse events were documented. One-month follow-up after treatment (TP3) was conducted to assess the intervention scheme's reliability. RESULTS VAS and Kofoed ankle scores significantly improved in both groups. No patients dropped due to adverse events. At TP1, there were no significant differences between the 2 groups in terms of VAS and Kofoed scores (P>0.05). However, at TP2, efficacy of MNK therapy in releasing the superficial fascia was significantly superior to that of acupuncture treatment (P<0.001). At TP3, no significant differences in scores existed between the groups (P>0.05). CONCLUSIONS This study demonstrates that 6 sessions of MNK therapy to release the superficial fascia safely and effectively alleviated pain and enhanced ankle joint function in patients with AAS, surpassing the efficacy of conventional acupuncture treatment. Future studies should increase the sample size and introduce additional control groups to further validate the superior clinical efficacy of this intervention.
微针刀(MNK)疗法松解浅筋膜,可缓解急性踝关节扭伤(AAS)患者的疼痛,改善关节功能。我们旨在评估 MNK 疗法与针灸的疗效和安全性。
这项盲法评估、随机对照试验将 80 例 AAS 患者按 1:1 比例分为 2 个平行组。实验组接受 MNK 治疗;对照组在特定穴位接受常规针灸治疗。采用视觉模拟评分(VAS)和 Kofoed 踝关节评分评估治疗前后(TP2)两组之间的临床疗效差异。记录安全性记录和不良事件评估。治疗后 1 个月(TP3)进行随访,以评估干预方案的可靠性。
两组 VAS 和 Kofoed 踝关节评分均显著改善。无患者因不良事件脱落。在 TP1 时,两组 VAS 和 Kofoed 评分无显著差异(P>0.05)。然而,在 TP2 时,MNK 疗法松解浅筋膜的疗效明显优于针灸治疗(P<0.001)。在 TP3 时,两组评分无显著差异(P>0.05)。
本研究表明,6 次 MNK 疗法松解浅筋膜安全有效,可缓解 AAS 患者的疼痛,增强踝关节功能,优于常规针灸治疗。未来的研究应增加样本量并引入额外的对照组,以进一步验证该干预措施的优越临床疗效。